Sarah Fremond, Leiden University Medical Centre, Leiden, The Netherlands, discusses the use of artificial intelligence (AI) in oncology for predicting the risk of distant recurrence and the associated challenges. This interview took place at the American Association for Cancer Research (AACR) Annual Meeting 2023 in Orlando, FL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.